Since COVID, market narratives seem to form more quickly and be applied more broadly. AI is increasingly framed as an ...

Good afternoon, and welcome to the Travere Therapeutics Business Update Conference Call. Today's call is being recorded. At this time, I would like to turn the conference call over to Nivi Nehra, Vice ...

Localization, done properly, isn't a content layer. It's an understanding of what a specific market actually responds to — ...

The San Francisco Zoo is facing a financial crisis, and city leaders are proposing a short-term multimillion-dollar loan ...

This new Azimut-SOQUEM alliance aims to unlock the nickel potential of a vast, largely underexplored region extending 360 ...

There has been a debate for years about how to address homelessness in Norman, with voters in 2020 saying no to a proposition ...

Origin Materials, Inc. (NASDAQ:ORGN) Q4 2025 Earnings Call Transcript March 27, 2026 Origin Materials, Inc. misses on ...

Bile Acid Medicines Sales -- $41 million attributed to CHOLBAM and CTEXLI medicines supported by expanded CTX patient finding ...

Operations, planning, finance, human resources and maintenance should be aligned through the schedules function.

CTEXLI approved by FDA for CTX; LIVMARLI approved in Japan for PFIC and Alagille syndrome with partner Takeda; and a single ...

In an order late Friday, U.S. District Court Judge Michael Liburdi blocked a proposed hearing set for Monday where Kalshi LLC ...